ESC-derived dopamine progenitor cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ESC-derived dopamine progenitor cell therapy, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of ESC-derived Dopamine Progenitor Cell Therapy in PD Patients [Phase 1, Phase 2]